Background Exposure to maternal immune activation (MIA) in utero is a risk factor for
neurodevelopmental disorders later in life. The impact of the gestational timing of MIA …

Exposure to maternal immune activation (MIA) in utero is a risk factor for
neurodevelopmental and psychiatric disorders. MIA-induced deficits in adolescent and adult …

Maternal immune activation (MIA) caused by exposure to pathogens or inflammation during
critical periods of neurodevelopment is a major risk factor for behavioral deficits and …

Human epidemiological studies implicate exposure to infection during gestation in the
etiology of neurodevelopmental disorders. Animal models of maternal immune activation …

In utero exposure to maternal immune activation (MIA) is an environmental risk factor for
neurodevelopmental and neuropsychiatric disorders. Animal models provide an opportunity …

Infectious or noninfectious maternal immune activation (MIA) is an environmental risk factor
for psychiatric and neurological disorders with neurodevelopmental etiologies. Whilst there …

Maternal infection during pregnancy increases the risk for neurodevelopmental disorders in
offspring. Rodent models have played a critical role in establishing maternal immune …

The adult brain is a complex structure with distinct functional sub-regions, which are
generated from an initial pool of neural epithelial cells within the embryo. This transition …

Maternal immune activation (mIA) during pregnancy is hypothesised to disrupt offspring
neurodevelopment and predispose offspring to neurodevelopmental disorders such as …

Gestational infection constitutes a risk factor for the occurrence of psychiatric disorders in the
offspring. Activation of the maternal immune system (MIA) with subsequent impact on the …